CD24 and laryngeal carcinoma: These results are in inverse relation to the ones found by Modur et al., showing that CD24 presence may lead to unfavorable cisplatin treatment outcome in laryngeal carcinoma cell lines, with a direct effect on cisplatin sensitivity and an indirect effect on apoptotic stem and drug resistance genes.